Evidence map›Paper›PMID 35516620›Full record

ArticleRSC advances2020

A titanium dioxide/nitrogen-doped graphene quantum dot nanocomposite to mitigate cytotoxicity: synthesis, characterisation, and cell viability evaluation.

Pravena Ramachandran, Chong Yew Lee, Ruey-An Doong, Chern Ein Oon, Nguyen Thi Kim Thanh, Hooi Ling Lee

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Recent nanotheranostic approaches in cancer research.Clinical and experimental medicine · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Pravena RamachandranNanomaterials Research Group, School of Chemical Sciences, Universiti Sains Malaysia 11800 USM Penang Malaysia hllee@usm.my.
Chong Yew LeeSchool of Pharmaceutical Sciences, Universiti Sains Malaysia 11800 USM Penang Malaysia.ORCID https://orcid.org/0000-0003-0632-3794
Ruey-An DoongInstitute of Analytical and Environmental Sciences, National Tsing Hua University Hsinchu 30013 Taiwan.ORCID https://orcid.org/0000-0002-4913-0602
Chern Ein OonInstitute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia 11800 USM Penang Malaysia.
Nguyen Thi Kim ThanhUCL Healthcare Biomagnetic and Nanomaterials Laboratories 21, Albemarle Street London W1S 4BS UK.ORCID https://orcid.org/0000-0002-4131-5952
Hooi Ling LeeNanomaterials Research Group, School of Chemical Sciences, Universiti Sains Malaysia 11800 USM Penang Malaysia hllee@usm.my.ORCID https://orcid.org/0000-0002-9637-0617
Universiti Sains Malaysia · MYLondon Centre for Nanotechnology · GBNational Tsing Hua University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Titanium dioxide nanoparticles (TiO

Identifiers

PMID35516620
PMCPMC9054499
OpenAlexW3035687630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.